{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T10:20:41Z","timestamp":1760955641742},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"19","license":[{"start":{"date-parts":[[2016,6,30]],"date-time":"2016-06-30T00:00:00Z","timestamp":1467244800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Defence Research and Development Organization, Ministry of Defence, India","award":["NBCD-14"],"award-info":[{"award-number":["NBCD-14"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Appl Microbiol Biotechnol"],"published-print":{"date-parts":[[2016,10]]},"DOI":"10.1007\/s00253-016-7684-4","type":"journal-article","created":{"date-parts":[[2016,6,30]],"date-time":"2016-06-30T04:39:31Z","timestamp":1467261571000},"page":"8439-8451","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Generation of a novel chimeric PALFn antigen of Bacillus anthracis and its immunological characterization in mouse model"],"prefix":"10.1007","volume":"100","author":[{"given":"Nagendra","family":"Suryanarayana","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Monika","family":"Verma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kulanthaivel","family":"Thavachelvam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nandita","family":"Saxena","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bharti","family":"Mankere","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Urmil","family":"Tuteja","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vanlal","family":"Hmuaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,6,30]]},"reference":[{"key":"7684_CR1","first-page":"321","volume":"160","author":"L Abrami","year":"2003","unstructured":"Abrami L, Liu S, Cosson P, Leppla SH, vander Goot FG (2003) Anthrax toxin triggers endocytosis of its receptor via lipid raft-mediated clathrin dependent process. J Chem Biol 160:321\u2013328","journal-title":"J Chem Biol"},{"key":"7684_CR2","doi-asserted-by":"crossref","first-page":"5425","DOI":"10.1128\/IAI.00261-07","volume":"75","author":"MT Albrecht","year":"2007","unstructured":"Albrecht MT, Li H, Williamson ED, LeButt CS, Flick-Smith HC, Quinn CP, Westra H, Galloway D, Mateczun A, Goldman S, Groen H, Baillie LWJ (2007) Human monoclonal antibodies against anthrax lethal factor and protective antigen act independently to protect against Bacillus anthracis infection and enhance endogenous immunity to anthrax. Infect Immun 75:5425\u20135433","journal-title":"Infect Immun"},{"key":"7684_CR3","doi-asserted-by":"crossref","first-page":"6740","DOI":"10.1016\/j.vaccine.2010.07.075","volume":"28","author":"LW Baillie","year":"2010","unstructured":"Baillie LW, Huwar TB, Moore S, Sanchez GM, Rodriguez L, Neeson BN, Flick-Smith HC, Jenner DC, Atkins HS, Ingram RJ, Altman DM, Nataro JP, Pasetti M (2010) An anthrax subunit vaccine candidate based on protective regions of Bacillus anthracis protective antigen and lethal factor. Vaccine 28:6740\u20136748","journal-title":"Vaccine"},{"key":"7684_CR4","doi-asserted-by":"crossref","first-page":"6155","DOI":"10.4049\/jimmunol.176.10.6155","volume":"176","author":"H Fang","year":"2006","unstructured":"Fang H, Xu L, Chen TY, Cyr JM, Frucht DM (2006) Anthrax lethal toxin has direct and potent inhibitory effects on B cell proliferation and immunoglobulin production. J Immunol 176:6155\u20136161","journal-title":"J Immunol"},{"key":"7684_CR5","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1093\/infdis\/167.5.1239","volume":"167","author":"AM Friedlander","year":"1993","unstructured":"Friedlander AM, Welkos SL, Pitt ML, Ezzell JW, Worsham PL, Rose KJ, Ivins BE, Lowe JR, Howe GB, Mikesell P, Lawrence WB (1993) Postexposure prophylaxis against experimental inhalation anthrax. J Infect Dis 167:1239\u20131243","journal-title":"J Infect Dis"},{"key":"7684_CR6","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1094\/PHYTO.2004.94.11.1245","volume":"94","author":"D Fritze","year":"2004","unstructured":"Fritze D (2004) Taxonomy of the genus Bacillus and related genera: the aerobic endospore-forming bacteria. Phytopathology 94:1245\u20131248","journal-title":"Phytopathology"},{"key":"7684_CR7","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1016\/j.vaccine.2003.09.043","volume":"22","author":"D Galloway","year":"2004","unstructured":"Galloway D, Liner A, Legutki J, Mateczun A, Barnewall R, Estep J (2004) Genetic immunization against anthrax. Vaccine 22:1604\u20131608","journal-title":"Vaccine"},{"key":"7684_CR8","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1128\/IAI.01217-08","volume":"77","author":"YP Gauthier","year":"2008","unstructured":"Gauthier YP, Tournier JN, Paucod JC, Corre JP, Mock M, Goossens PL, Vidal DR (2008) Efficacy of a vaccine based on protective antigen and killed spores against experimental inhalational anthrax. Infect Immun 77:1197\u20131207","journal-title":"Infect Immun"},{"key":"7684_CR9","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/S1369-5274(02)00359-4","volume":"5","author":"PH Gilligan","year":"2002","unstructured":"Gilligan PH (2002) Therapeutic challenges posed by bacterial bioterrorism threats. Curr Opin Microbiol 5:489\u2013495","journal-title":"Curr Opin Microbiol"},{"key":"7684_CR10","first-page":"13601","volume":"101","author":"G Hermanson","year":"2004","unstructured":"Hermanson G, Whitlow V, Parker S, Tonsky K, Rusalov D, Ferrari M, Lalor P, Komal M, Mere R, Bell M, Brenneman K, Mateczun A, Evans T, Kaslow D, Galloway D, Hobart P (2004) A cationic lipid formulated plasmid DNA confers sustained antibody mediated protection against aerosolized anthrax spores. PLoS One 101:13601\u201313606","journal-title":"PLoS One"},{"key":"7684_CR11","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1016\/0264-410X(94)90027-2","volume":"12","author":"B Ivins","year":"1994","unstructured":"Ivins B, Fellows PF, Nelson GO (1994) Efficacy of standard human anthrax vaccine against Bacillus anthracis spore challenge in guinea pigs. Vaccine 12:872\u2013874","journal-title":"Vaccine"},{"key":"7684_CR12","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1016\/S0264-410X(98)80112-6","volume":"16","author":"BE Ivins","year":"1998","unstructured":"Ivins BE, Pitt MLM, Fellows PF, Farchaus JW, Benner GE, Waag DM, Little SF, Anderson GW Jr, Gibbs PH, Friedlander AM (1998) Comparative efficacy of experimental anthrax vaccine candidates against inhalation anthrax in rhesus macaques. Vaccine 16:1141\u20131148","journal-title":"Vaccine"},{"key":"7684_CR13","unstructured":"Kaur, M., Chug H, Singh H, Chandra S, Mishra M, Sharma M, Bhatnagar R (2009) Identification and characterization of immunodominant B cell epitope of the C terminus of protective antigen of Bacillus anthracis. Mol Immunol. 46: 2107- 2115Kobiler D, Gozes Y, Rosenberg H, Marcus D, Reuveny S, Altboum Z (2002) Efficiency of protection of guinea pigs against infection with\u00a0Bacillus anthracis\u00a0spores by passive immunization. Infect Immun 70:544\u2013550"},{"key":"7684_CR14","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1128\/CVI.00240-12","volume":"19","author":"EK Leffel","year":"2012","unstructured":"Leffel EK, Bourdage JS, Williamson ED, Duchars M, Fuerst TR, Fusco PC (2012) Recombinant protective antigen anthrax vaccine improves survival when administered as a postexposure prophylaxis countermeasure with antibiotic in the New Zealand white rabbit model of inhalation anthrax. Clin Vaccine Immunol 19:1158\u20131164","journal-title":"Clin Vaccine Immunol"},{"key":"7684_CR15","doi-asserted-by":"crossref","first-page":"92","DOI":"10.2174\/1875035400902010092","volume":"2","author":"Q Li","year":"2009","unstructured":"Li Q, Peachman KK, Sower L, Leppla SH, Shivachandra SB, Matyas GR, Peterson JW, Alwing CR, Rao M, Rao VB (2009) Anthrax LFn-PA hybrid antigens: biochemistry, immunogenicity, and protection against lethal ames spore challenge in rabbits. Open Vaccine J 2:92\u201399","journal-title":"Open Vaccine J"},{"key":"7684_CR16","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1128\/IAI.56.7.1807-1813.1988","volume":"56","author":"SF Little","year":"1988","unstructured":"Little SF, Leppla SH, Cora E (1988) Production and characterization of monoclonal antibodies to the protective antigen of Bacillus anthracis toxin. Infect Immun 56:1807\u20131813","journal-title":"Infect Immun"},{"key":"7684_CR17","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.coi.2009.05.010","volume":"21","author":"LJ McHeyzer-Williams","year":"2009","unstructured":"McHeyzer-Williams LJ, Pelletier N, Mark L, Fazilleau N, McHeyzer-Williams MG (2009) Follicular helper T cells as cognate regulators of B cell immunity. Curr Opin Immunol 21:266\u2013273","journal-title":"Curr Opin Immunol"},{"key":"7684_CR18","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.toxicon.2015.10.004","volume":"108","author":"S Nagendra","year":"2015","unstructured":"Nagendra S, Vanlalhmuaka VS, Tuteja U, Thavachelvam K (2015) Recombinant expression of Bacillus anthracis lethal toxin components of Indian isolate in Escherichia coli and determination of its acute toxicity level in mouse model. Toxicon 108:108\u2013114","journal-title":"Toxicon"},{"key":"7684_CR19","doi-asserted-by":"crossref","first-page":"715","DOI":"10.2105\/AJPH.92.5.715","volume":"92","author":"M Nass","year":"2002","unstructured":"Nass M (2002) The anthrax vaccine program: an analysis of the CDC\u2019s recommendations for vaccine use. Am J Public Health 92:715\u2013721","journal-title":"Am J Public Health"},{"key":"7684_CR20","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/j.bbrc.2010.07.039","volume":"398","author":"ZH Newman","year":"2010","unstructured":"Newman ZH, Crown D, Leppla SH, Moayeri M (2010) Anthrax lethal toxin activates the inflammasome in sensitive rat macrophages. Biochem Biophys Res Commun 398:785\u2013789","journal-title":"Biochem Biophys Res Commun"},{"key":"7684_CR21","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.3390\/toxins2071612","volume":"2","author":"O Odumosu","year":"2010","unstructured":"Odumosu O, Nicholas D, Yano H, Langridge W (2010) AB toxins: a paradigm switch from deadly to desirable. Toxins 2:1612\u20131645","journal-title":"Toxins"},{"key":"7684_CR22","doi-asserted-by":"crossref","first-page":"6509","DOI":"10.1128\/JB.181.20.6509-6515.1999","volume":"181","author":"RT Okinaka","year":"1999","unstructured":"Okinaka RT, Cloud K, Hampton O, Hoffmaster AR, Hill KK, Keim P, Koehler TM, Lamke G, Kumano S, Mahillon J, Manter D, Martinez Y, Ricke D, Svensson R, Jackson PJ (1999) Sequence and organization of pXO1, the large Bacillus anthracis plasmid harboring the anthrax toxin genes. J Bacteriol 181:6509\u20136515","journal-title":"J Bacteriol"},{"key":"7684_CR23","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1128\/IAI.63.4.1369-1372.1995","volume":"63","author":"C Pezard","year":"1995","unstructured":"Pezard C, Weber M, Sirard JC, Berche P, Mock M (1995) Protective immunity induced by Bacillus anthracis toxin deficient strains. Infect Immun 63:1369\u20131372","journal-title":"Infect Immun"},{"key":"7684_CR24","doi-asserted-by":"crossref","first-page":"4509","DOI":"10.1128\/IAI.69.7.4509-4515.2001","volume":"69","author":"BM Price","year":"2001","unstructured":"Price BM, Liner AL, Park S, Leppla SH, Mateczun A, Galloway DR (2001) Protection against anthrax lethal toxin challenge by genetic immunization with a plasmid encoding the lethal factor protein. Infect Immun 69:4509\u20134515","journal-title":"Infect Immun"},{"key":"7684_CR25","doi-asserted-by":"crossref","first-page":"2888","DOI":"10.1128\/IAI.69.5.2888-2893.2001","volume":"69","author":"S Reuveny","year":"2001","unstructured":"Reuveny S, White MD, Adar YY, Kafri Y, Altboum Z, Gozes Y, Kobiler D, Shafferman A, Velan B (2001) Search for correlates of protective immunity conferred by anthrax vaccine. Infect Immun 69:2888\u20132893","journal-title":"Infect Immun"},{"key":"7684_CR26","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1080\/08998280.2005.11928074","volume":"18","author":"S Riedel","year":"2005","unstructured":"Riedel S (2005) Anthrax: a continuing concern in the era of bioterrorism. Baylor Univ Med Cent Proc 18:234\u2013243","journal-title":"Baylor Univ Med Cent Proc"},{"key":"7684_CR27","volume-title":"Molecular cloning: a laboratory manual","author":"J Sambrook","year":"1989","unstructured":"Sambrook J, Fritsch EF, Maniatis T (1989) Molecular cloning: a laboratory manual, vol 3. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y."},{"key":"7684_CR28","doi-asserted-by":"crossref","first-page":"5170","DOI":"10.1073\/pnas.0431098100","volume":"100","author":"HM Scobie","year":"2003","unstructured":"Scobie HM, Rainey GJ, Bradley KA, Young JA (2003) Human capillary morphogenesis protein 2 functions as an anthrax toxin receptor. Proc Natl Acad Sci 100:5170\u20135174","journal-title":"Proc Natl Acad Sci"},{"key":"7684_CR29","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1136\/jcp.56.3.182","volume":"56","author":"RC Spencer","year":"2003","unstructured":"Spencer RC (2003) Bacillus anthracis. J Clin Pathol 56:182\u2013187","journal-title":"J Clin Pathol"},{"key":"7684_CR30","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.3201\/eid1404.070969","volume":"14","author":"E Stern","year":"2008","unstructured":"Stern E, Uhde K, Shadomy S, Messonnier N (2008) Conference report on public health and clinical guidelines for anthrax. Emerg Infect Dis 14:e1","journal-title":"Emerg Infect Dis"},{"key":"7684_CR31","doi-asserted-by":"crossref","first-page":"2455","DOI":"10.1128\/IAI.00839-08","volume":"77","author":"SE Szarowicz","year":"2009","unstructured":"Szarowicz SE, During RL, Li W, Quinn CP, Tang WJ, Southwick FS (2009) Bacillus anthracis edema toxin impairs neutrophil actin based motility. Infect Immun 77:2455\u20132464","journal-title":"Infect Immun"},{"key":"7684_CR32","first-page":"557","volume":"132","author":"I Uchida","year":"1986","unstructured":"Uchida I, Hashimoto K, Terakado N (1986) Virulence and immunogenicity in experimental animals of Bacillus anthracis strains harbouring or lacking 110\u00a0MDa and 60\u00a0MDa plasmids. J Gen Microbiol 132:557\u2013559","journal-title":"J Gen Microbiol"},{"key":"7684_CR33","doi-asserted-by":"crossref","first-page":"7813","DOI":"10.1073\/pnas.0602748103","volume":"103","author":"NJ Vietri","year":"2006","unstructured":"Vietri NJ, Purcell BK, Lawler JV, Leffel EK, Rico P, Gamble CS, Twenhafel NA, Ivins BE, Heine HS, Sheeler R, Wright ME, Friedlander AM (2006) Short-course postexposure antibiotic prophylaxis combined with vaccination protects against experimental inhalational anthrax. Proc Natl Acad Sci USA 103:7813\u20137816","journal-title":"Proc Natl Acad Sci USA"},{"key":"7684_CR34","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.2105\/AJPH.2006.102749","volume":"97","author":"MM Weiss","year":"2007","unstructured":"Weiss MM, Weiss PD, Weiss JB (2007) Anthrax vaccine and public health policy. Am J Public Health 97:1945\u20131951","journal-title":"Am J Public Health"},{"key":"7684_CR35","doi-asserted-by":"crossref","first-page":"4750","DOI":"10.1128\/AAC.00640-10","volume":"54","author":"G Wu","year":"2010","unstructured":"Wu G, Hong Y, Guo A, Feng C, Cao S, Zhang CC, Shi R, Tan Y, Liu Z (2010) Chimeric protein that functions as both an anthrax dual-target antitoxin and a trivalent vaccine. Antimicrob Agents Chemother 54:4750\u20134757","journal-title":"Antimicrob Agents Chemother"},{"key":"7684_CR36","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1128\/CVI.00402-07","volume":"15","author":"Q Xu","year":"2008","unstructured":"Xu Q, Zeng M (2008) Detoxified lethal toxin as a potential mucosal vaccine against anthrax. Clin Vaccine Immunol 15:612\u2013616","journal-title":"Clin Vaccine Immunol"},{"key":"7684_CR37","doi-asserted-by":"crossref","first-page":"129","DOI":"10.3233\/HAB-2003-12404","volume":"12","author":"P Zhao","year":"2003","unstructured":"Zhao P, Liang X, Kalbfleisch J, Koo HM, Ca B (2003) Neutralizing monoclonal antibody against anthrax lethal factor inhibits intoxication in a mouse model. Hum Antibodies 12:129\u2013135","journal-title":"Hum Antibodies"}],"container-title":["Applied Microbiology and Biotechnology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00253-016-7684-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00253-016-7684-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00253-016-7684-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,23]],"date-time":"2020-09-23T04:17:45Z","timestamp":1600834665000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00253-016-7684-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,6,30]]},"references-count":37,"journal-issue":{"issue":"19","published-print":{"date-parts":[[2016,10]]}},"alternative-id":["7684"],"URL":"https:\/\/doi.org\/10.1007\/s00253-016-7684-4","relation":{},"ISSN":["0175-7598","1432-0614"],"issn-type":[{"value":"0175-7598","type":"print"},{"value":"1432-0614","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,6,30]]}}}